In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

What makes the human brain distinctive? A new study published July 21 in Cell identifies two genes linked to human brain ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) saw its stock surge 19% Monday morning following the announcement of its ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts. On July 8, ...

One computer scientist’s “stunning” proof is the first progress in 50 years on one of the most famous questions in computer ...

The University of Washington's Allen School is rethinking how to train the next generation of software engineers in an ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...

Rallybio Corp., a New Haven-based biotechnology company developing therapies for rare diseases, said Tuesday it has agreed to ...

Investing.com -- Recursion Pharmaceuticals Inc (NASDAQ: RXRX) stock surged 11.5% while Rallybio Corp (NASDAQ: RLYB) shares jumped 35% Monday after Recursion acquired full rights to REV102, an oral ...